And why it’s about to become the next big thing in longevity science
Category: life extension
Good channel here.
The future of human longevity just got a $500billion booste thanks to Trump’s bold new AI vision! In this video, we explore the recently announced Stargate AI Infrastructure Project—a staggering $500 billion initiative unveiled by President Donald Trump on January 21, 2025, alongside tech titans OpenAI, Oracle, and SoftBank. Designed to build colossal data centers and supercharge AI development, could this ambitious plan hold the key to curing aging? We dive into the cutting-edge science, the potential of AI to revolutionize healthcare, and how Stargate might reshape humanity’s fight against time. Buckle up for a wild ride into the future!
🔍 What You’ll Discover:
The Stargate Project: Trump’s massive AI infrastructure gamble.
How AI could unlock breakthroughs in aging research.
The players: OpenAI, Oracle, SoftBank, and their bold vision.
The big question: Can this tech triumph over mortality?
JOIN LSN Patreon for exclusive access to news, tips and a community of like minded longevity enthusiasts: https://www.patreon.com/user?u=29506604
🔔 Like, subscribe, and hit the bell for more groundbreaking insights every week! Tell us in the comments: Do you think Stargate could be the key to curing aging? Let’s debate it!
Scientists are looking at ways to tackle Alzheimer’s and dementia from all kinds of angles, and a new study has identified the molecule hevin (or SPARCL-1) as a potential way of preventing cognitive decline.
Hevin is a protein naturally produced in the brain by cells called astrocytes. These support-worker cells look after the connections or synapses between neurons, and it’s thought that hevin plays a role in this essential work.
In this new study, researchers from the Federal University of Rio de Janeiro (UFRJ) and the University of São Paulo in Brazil boosted hevin production in the brains of both healthy mice and those with an Alzheimer’s-like disease.
Cells are constantly subjected to DNA damage from a range of internal and environmental sources. It is estimated that cells can experience as many as 100,000 DNA lesions per day. One of the most deleterious types of DNA lesions is the DNA double-strand break (DSB). Just one unrepaired DNA DSB may be enough to cause mutations or cell death leading to a wide range of pathologies including cancer, immune deficiency, premature aging and neurodegeneration.
To respond to the array of DNA lesions that occur, cells have developed a complex and coordinated series of steps involving DNA damage recognition, cell cycle arrest and signaling-induced activation of the DNA repair machinery—processes collectively referred to as the DNA damage response (DDR). In recent years, progress has been made in understanding how this process is initiated. However, the later stages of this process, including long range DNA end-resection, are not well understood.
In a new study published in Nature Cell Biology, researchers from Boston University Chobanian & Avedisian School of Medicine, Massachusetts General Hospital (MGH) and Harvard Medical School, identified several uncharacterized chromatin factors (proteins that regulate gene expression) that are recruited to sites of DNA damage, including the gene ZNF280A. Importantly, this gene is hemizygously deleted—meaning one of the two copies of alleles is missing—in a subset of patients with a human developmental syndrome called 22q11.2 distal deletion syndrome.
Hey! If anyone’s interested in attending the Viva Frontier Tower Longevity Summit in SF this weekend (Aubrey de Grey and Irina Conboy, plus a ton of others, are speaking) I have a couple 60% coupons I can share. Shoot me a DM!
On June 22–23, the Longevity Summit hosted during the 6-week Viva Frontier Tower Pop-up Village (Jun 20 — Aug 4) will serve two purposes:
What if reversing cellular aging could be achieved by overexpressing just a single gene? In this video, I break down Shift Bioscience’s latest preprint, whic…
Dr. Mohammed Enayat has access to all sorts of experimental antiaging treatments at his clinic, but a core part of his longevity routine is pretty cheap and accessible: supplements.
Enayat told Business Insider that his most recent “biological age” tests, taken 18 months ago, said he was 24, or 17 years younger than his chronological age of 41. There’s no consensus on how to define or measure biological age, but Enayat used GlycanAge and TruAge PACE, which measure inflammation and epigenetics, respectively.
The primary care doctor, who’s also the founder of London’s Hum2n longevity clinic, has been closely tracking his health for the past seven years, using wearable tech, including an Oura ring and a Whoop strap, plus regular blood, urine, and microbiome tests.
Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD
Discount Links/Affiliates:
Blood testing (where I get the majority of my labs): https://www.ultalabtests.com/partners/michaellustgarten.
At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.
Clearly Filtered Water Filter: https://get.aspr.app/SHoPY
Epigenetic, Telomere Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING
NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
SENS Research Foundation works to develop, promote, and ensure widespread access to therapies that cure and prevent the diseases and disabilities of aging by comprehensively repairing the damage that builds up in our bodies over time.
A real AI drug lab is now building the future of longevity. In Abu Dhabi. With $76 million.